本システムでは、JavaScriptを利用しています。JavaScriptを有効に設定してからご利用ください。

【参】六角形画像(NEWS)

H1

NEWS

パンくずリスト

ホーム > Kidswell Bio Corporation > NEWS

★IR：カテゴリメニュー

タブV2

All
IR Library
Topics

2019/11/22

Announcement on Series B Funding by Heartseed Inc.

We are pleased to announce that Heartseed Inc., our investee company, has raised Series B funding.
For the details, please refer to the link below.

Heartseed Inc.
Heartseed raises $26 Million in Series B Funding
http://www.heartseed.jp/pdf/191122_PR_E.pdf

2025/10/29

IR Library

"Treg" with "SHED" Toward the Development of an Innovative Immune Cell Therapy -Joint Research Agreement with Tokyo University of Science- [PDF：141KB]
2025/10/16

IR Library

Toward a New Infertility Treatment Utilizing SHED - Commencement of Joint Research with LYMPHOGENiX (UK) - [PDF：176KB]
2025/10/08

IR Library

Collaborative Research Results with S-Quatre to be Presented by Nagoya University at the 75th Congress of Neurological Surgeons in Los Angels (CNS 2025)
2025/10/07

IR Library

SHED Clinical Study for Cerebral Palsy Data Safety Monitoring Board Confirms "No Safety Concerns" [PDF：240KB]
2025/10/06

IR Library

Execution of Agreements regarding the Joint Development of Biosimilars for Specified Products [PDF：102KB]
2025/10/06

IR Library

Agreement in Principle to Establish a Joint Venture Alliance for the Development of Domestic Manufacturing Facility for Biosimilars [PDF：98KB]
2025/09/25

IR Library

1Q FY2025 update from OMEGA Investment [PDF：749KB]
2025/08/14

IR Library

Publication of Research Paper on the Application of SHED in the Treatment of Peripheral Nerve Injuries [PDF：244KB]
2025/08/13

IR Library

Financial Results for FY2025 Q1 [PDF：1324KB]
2025/08/13

IR Library

Summary of Consolidated Financial Results for the Fiscal Year Ended March 31, 2026 [PDF：371KB]

1
2
3
4
5
6
7
8
9
10
次へ

2019/11/22

topics

Announcement on Series B Funding by Heartseed Inc.
2019/05/10

topics

Notice of Relocation of Head Office Function, Relocation of Tokyo Office, and Integration of Subsidiaries office [PDF：137KB]
2019/05/10

topics

Announcement of signing a joint research and development agreement with ORTHOREBIRTH for cleft lip/cleft palate [PDF：198KB]
2019/03/12

topics

Notice of Resolutions at the Extraordinary General Shareholders Meeting [PDF：297KB]
2019/02/28

topics

Completion of the enrollment of the final patient in the Phase III study for ophthalmologic biosimilar [PDF：78KB]
2019/02/05

topics

FY2018 3Q IR Meeting Information [PDF：2408KB]
2019/01/31

topics

GTS and Senju sign a licensing agreement with Ocumension Therapeutics on biosimilar in ophthalmologic field [PDF：93KB]
2019/01/17

topics

[Presentation] Execution of Share Exchange Agreement and Conversion of Advanced Cell Technology and Engineering into Wholly-Owned Subsidiary of Kidswell Bio Corporation [PDF：1833KB]
2019/01/17

topics

[Announcement] Execution of Share Exchange Agreement and Conversion of Advanced Cell Technology and Engineering into Wholly-Owned Subsidiary of Kidswell Bio Corporation [PDF：348KB]
2018/09/28

topics

Submission of New Drug Application in Japan of Darbepoetin alfa Biosimilar [PDF：169KB]

1
2
3
4
次へ